|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Challenges
|
|
|
| • |
Inconsistency of
form
|
|
|
|
– |
Consent for
tissue
|
|
|
incorporated in
consent for
|
|
participation in
clinical trial
|
|
|
|
– |
Consent choices
in the
|
|
|
middle of the
form, often
|
|
|
not in context
|
|
|
|
– |
Patient can be unclear
|
|
|
about what s/he
is
|
|
|
consenting to
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Solutions
|
|
|
| • |
Involved
constituencies
|
|
|
needed to
revisit templates
|
|
|
|
– |
Consent for use
of tissue
|
|
|
should be
separate unless a
|
|
|
requirement for
participating
|
|
|
in a study
|
|
|
|
– |
All consent
choices should
|
|
|
be at the end of
the form
|
|
|
|
– |
General
statements about the
|
|
future use of
tissue rather
|
|
|
than try to
predict uses
|
|
|
|